CDC / NCIRD 2009 Adult Vaccine Contract

The Centers for Disease Control and Prevention (CDC) will issue a Request for Proposals (RFP) for a multiple award, Indefinite Delivery, Indefinite Quantity (IDIQ) Firm Fixed Price (FFP) contract to purchase standard commercial adult vaccines that have been manufactured under a current product license issued by the U.S Food and Drug Administration (FDA). The CDC anticipates awarding multiple contracts to various vaccine manufacturers and/or distributors for the following vaccines:

(1) Hepatitis A adult vaccine
(2) Hepatitis B adult vaccine
(3) Combination Hepatitis A&B vaccine
(4) Pneumococcal Polysaccharide vaccine
(5) Tetanus and Diphtheria Toxoids vaccine for adults
(6) Herpes Zoster vaccine
(7) Tetanus Toxoid, Reduced Diphtheria Toxoid with Acellular Pertussis
Adsorbed
(8) Measles, Mumps, and Rubella
(9) Meningococcal Conjugate
(10) Quadrivalent Human Papillomavirus types 6, 11, 16 and 18 recombinant vaccine
(11) Varicella

Vaccines purchased through this contracting vehicle are acquired for the CDC / National Center for Immunization and Respiratory Disease (NCRID's ) adult vaccine program that encompasses immunization grantees from the fifty state health departments, several large city health care programs, and former U.S Territories - as provided under Section 317(j) of the Public Health Service Act. Information regarding maximum estimated quantities, minimum order sizes, and shelf life requirements are listed in the RFP. Vaccines shall be shipped F.O.B. destination. The contract period of performance is twelve (12) consecutive months, beginning on or about 7/1/09. Offerors must provide evidence of current Food and Drug Administration (FDA) product licenses for all vaccines. Solicitation Number 2009-N-11276 will be posted on the Government wide Point of Entry (GPE) www.fedbizopps.gov on or about 5/11/2008. All responsible sources may submit a proposal, which shall be considered by the agency if received on or before the designated due date. Interested parties should contact Mr. Russell Oxford, the CDC Point of Contact for this notice, at phone number 770-488-2082 or email: roxford@cdc.gov on or before 05/10/2009 to confirm their intent to submit an offer following receipt of the CDC's Request for Proposal (RFP).